Advisory Board
American Conference Institute’s Life Sciences IP Due Diligence Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers from the leading pharmaceutical companies in the country. This ‘inner circle’ counsels ACI on the impact of emerging trends and current best practices.

Wei Campbell
Director, Patent Counsel
Alnylam Pharmaceuticals (Cambridge, MA)

Hilary Libka
Chief IP Counsel, Associate General Counsel
Memorial Sloan-Kettering Cancer Center

Forrester Liddle
Head of IP and Legal, US R&D
Novo Nordisk

Kiera Mathey
Assistant General Counsel, Patents
Johnson & Johnson

Sapna Mehtani, Ph.D., J.D.
Head of IP
Abcam, Inc, a Danaher company
